Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Carcinoma;Blood”

3,148 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 3,148 results

Not applicableWithdrawnNCT03942900
What this trial is testing

Immunomonitoring and Biomarker Research in Patients With Squamous Cell Anal Carcinoma

Who this might be right for
Anal Canal Cancer
Centre Hospitalier Universitaire de Besancon
Testing effectiveness (Phase 2)Study completedNCT00445900
What this trial is testing

Thalidomide, Prednisone, and Cyclophosphamide in Treating Patients With Myelofibrosis and Myeloid Metaplasia

Who this might be right for
Chronic Myeloproliferative DisordersSecondary Myelofibrosis
Mayo Clinic 22
Testing effectiveness (Phase 2)Active Not RecruitingNCT04439136
What this trial is testing

Testing Afatinib as a Potential Targeted Treatment in Cancers With HER2 Genetic Changes (MATCH-Subprotocol B)

Who this might be right for
Advanced LymphomaAdvanced Malignant Solid NeoplasmHematopoietic and Lymphoid Cell Neoplasm+3 more
National Cancer Institute (NCI) 40
Testing effectiveness (Phase 2)Study completedNCT00004907
What this trial is testing

Chemotherapy and Radiation Therapy Plus Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory T-cell Lymphoma, Hodgkin's Lymphoma, or Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Northwestern University
Not applicableLooking for participantsNCT06843707
What this trial is testing

Establishing a Longitudinal Cohort Study of Lung Cancer Using Tissue and Peripheral Blood Metabolomics.

Who this might be right for
Lung CancerLungLung Cancer (NSCLC)+1 more
The First Affiliated Hospital of Guangzhou Medical University 2,500
Not applicableStudy completedNCT05147311
What this trial is testing

Positive Psychology Intervention In HSCT

Who this might be right for
Hematologic MalignancyHematopoietic/Lymphoid CancerBlood Cancer
Brigham and Women's Hospital 72
Early research (Phase 1)Study completedNCT01195311
What this trial is testing

A Dose-escalation Study in Subjects With Advanced Malignancies

Who this might be right for
Solid Tumors and Hematologic Malignancy
Incyte Corporation 52
Testing effectiveness (Phase 2)Study completedNCT00405743
What this trial is testing

A Phase I/II Study of CP-4055 in Patients With Refractory/Relapsed Hematologic Malignancies

Who this might be right for
Hematologic MalignanciesAML
Clavis Pharma 153
Not applicableStudy completedNCT05406089
What this trial is testing

Effects of Antiviral Therapy on Patients With HBV-related HCC

Who this might be right for
Hepatocellular CarcinomaHepatitis B VirusSurvival
First Affiliated Hospital Xi'an Jiaotong University 494
Not applicableLooking for participantsNCT07224750
What this trial is testing

A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer

Who this might be right for
Hepatocellular Carcinoma (HCC)CholangiocarcinomaPancreatic Ductal Adenocarcinoma (PDAC)+3 more
City of Hope Medical Center 1,000
Early research (Phase 1)UnknownNCT02457650
What this trial is testing

T Cell Receptor-transduced T Cells Targeting NY-ESO-1 for Treatment of Patients With NY-ESO-1- Expressing Malignancies

Who this might be right for
Bladder CarcinomaBreast CancerEsophagus Carcinoma+7 more
Shenzhen Second People's Hospital 36
Very early researchEnded earlyNCT04150874
What this trial is testing

Contrast-Enhanced Ultrasound for the Evaluation of Changes in Tumor Blood Flow Surrounding HAE

Who this might be right for
Hepatocellular CarcinomaLiver Cancer
H. Lee Moffitt Cancer Center and Research Institute 4
Early research (Phase 1)Looking for participantsNCT07755397
What this trial is testing

First in Human Multicenter Open Name Dose-increase, Consolidation Method to Study Safety Drug-level in Blood & Drug Metabolism Clinical Activity of Oral JBI-778 in Lung Cancer Patients With, Without Brain Metastasis IDH Mutated WHO Grade 3,4 Recurrent Glioma, Salivary Glands Tumor

Who this might be right for
NSCLC Patients With EGFR Activating MutationAdenoid Cystic Carcinoma MetastaticAdenoid Cystic Carcinoma of the Head and Neck
Jubilant Therapeutics India Limited 30
Testing effectiveness (Phase 2)Ended earlyNCT03933813
What this trial is testing

Evaluation and Treatment of Iron Deficiency in Ovarian Cancer Patients

Who this might be right for
Epithelial Ovarian CancerAnemiaIron Deficiency Anemia
University of Wisconsin, Madison 9
Early research (Phase 1)Looking for participantsNCT06909474
What this trial is testing

Clinical Trial of CD5-targeted CAR-NK Therapy for Relapse/Refractory T-Cell Hematologic Malignancies

Who this might be right for
T-ALL/Lymphoma
Chongqing Precision Biotech Co., Ltd 15
Testing effectiveness (Phase 2)Study completedNCT04112810
What this trial is testing

Tildrakizumab for Prevention of Acute Graft-Versus-Host Disease

Who this might be right for
Hematologic Malignancies
Medical College of Wisconsin 51
Testing effectiveness (Phase 2)Study completedNCT00051597
What this trial is testing

A Safety/Efficacy Study of SGN-30 (Antibody) in Patients With Refractory or Recurrent CD30+ Hematologic Malignancies

Who this might be right for
Hodgkin DiseaseLymphoma, Large-CellSarcoma, Kaposi+2 more
Seagen Inc. 70
Not applicableStudy completedNCT04172818
What this trial is testing

Feasibility Study of a Diary for Allogenic Hematopoietic Stem Cell Transplantation Patients and Families

Who this might be right for
Hematopoietic/Lymphoid CancerPsychological Disorder
Centre Hospitalier Universitaire, Amiens 20
Testing effectiveness (Phase 2)Looking for participantsNCT04068597
What this trial is testing

Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies

Who this might be right for
Haematological MalignancyAcute Myeloid LeukemiaNon Hodgkin Lymphoma+3 more
CellCentric Ltd. 250
Testing effectiveness (Phase 2)Ended earlyNCT03187756
What this trial is testing

Study of Nonmyeloablative Peripheral Blood Stem Cell Transplant With High-dose Posttransplantation Cyclophosphamide in Hematopoietic Malignancies Including Those That Are Challenging to Engraft

Who this might be right for
Hematopoietic Malignancies
NYU Langone Health 6
Next Page